Filing Details

Accession Number:
0001209191-22-016540
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-04 21:18:01
Reporting Period:
2022-03-02
Accepted Time:
2022-03-04 21:18:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1029142 Dynavax Technologies Corp DVAX Pharmaceutical Preparations (2834) 330728374
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1573072 F David Novack C/O Dynavax Technologies
2100 Powell Street, Suite 900
Emeryville CA 94608
President & Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-15 1,009 $10.29 97,575 No 4 A Direct
Common Stock Acquisiton 2022-03-02 17,500 $0.00 115,075 No 4 M Direct
Common Stock Disposition 2022-03-03 10,783 $10.57 104,292 No 4 S Direct
Common Stock Disposition 2022-03-03 31,079 $10.57 73,213 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Acquisiton 2022-03-02 17,500 $0.00 17,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
35,000 No 4 M Direct
Footnotes
  1. Includes 1,009 shares acquired under issuer's 2014 Employee Stock Purchase Plan (ESPP) on February 15, 2022.
  2. Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annualanniversary of February 3, 2021.
  3. The reporting person is reporting the sale of 10,783 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on March 2, 2022.
  4. The reporting person is reporting the sale of 31,079 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on March 2, 2022. The conversion of the RSUs into common stock was reported on the reporting person's Form 4 on February 14, 2022.